SMi’s 3rd annual Lyophilisation & Freeze Drying USA conference will take place on the 29th & 30th April 2015 in Iselin, New Jersey, USA

ISELIN, NEW JERSEY, USA, January 13, 2015 /EINPresswire.com/ -- With the American region dominating the market for lyophilised pharmaceutical products, growing demand has contributed to a projected rise in investment to reach $4.80 billion by 2020. SMi’s 3rd conference in the successful Lyophilisation series, Lyophilisation & Freeze Drying USA, comes at the perfect time and place on 29th & 30th April 2015 to Iselin, New Jersey, USA.

SMi have worked closely with a leading panel of experts such as Genentech, GSK, MedImmune, Merck, Genzyme, Bristol-Myers Squibb, Genzyme and Novo Nordisk, to create an agenda that will provide unique insight into topics such as lyophilisation and freeze drying developments, QbD, process analytical techniques & strategies, plus much more.

Key speakers include:

• Swapnil Pansare, Associate Scientist – I, Formulation Sciences, MedImmune
• Akhilesh Bhambhani, Principal Scientist, Novel Adjuvants, Formulations and Delivery Technologies, Merck & Co. Inc.
• Vikram Sadineni, Senior Research Investigator-II, Bristol-Myers Squibb
• Mark Yang, Director, Fill Finish Development, Genzyme
• Sune Andersen, Principal Scientist in Drying Processes and Particle, Technology in CMC, Novo Nordisk A/S, Denmark
• Graham Magill, Engineer I, Pharmaceutical Processing and Technology Development, Genentech Inc.
• Ronald Pate, Lyophilisation Development Scientist, Patheon Pharmaceuticals Inc.

For further details and to download a brochure visit http://www.smi-online.co.uk/goto/2015lyophilisationusa5.asp

Lyophilisation USA will aim to:

• Focus on process formulation and optimisation for biologics and vaccines with a key emphasis on the development of lyophilisation and scale up
• All challenges in lyophilisation and freeze drying technology will be considered and case studies will reflect and address the implementation process
• Provide an up-to-date perspective of the lyophilisation process as a whole and the application in formulating solid protein pharmaceuticals. This conference will review the challenges to enhance improvements
• Provide attendees with a forum for debate in a round table discussion, focusing on quality by design and the future of lyophilisation

Sponsored by Ellab Inc, iQ Mobil, Millrock Technology, One 2 One Hospira and SP Scientific

For those who are interested in attending there is currently a £400 discount available onlne. For further information and to register visit http://www.smi-online.co.uk/goto/2015lyophilisationusa5.asp

-------------------------- END --------------------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0) 20 7827 6162
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.